A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients

Objectives: Tenofovir DF (TDF) remains one of the preferred backbone agents for naïve HIV patients starting antiretroviral treatment (ART). The impact of TDF on renal function and metabolic parameters may vary by anchor agent. We investigated the impact of TDF in combination with 3 different integra...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Margherita Bracchi, Nicole Pagani, Alessia Dalla Pria, Ana Milinkovic, Nneka Nwokolo, Lervina Thomas, Sundhyia Mandalia, Marta Boffito, Graeme Moyle
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Taylor & Francis Group 2021-11-01
श्रृंखला:	HIV Research & Clinical Practice
विषय:	hiv tenofovir df raltegravir dolutegravir elvitegravir/cobicistat renal function tubular function
ऑनलाइन पहुंच:	http://dx.doi.org/10.1080/25787489.2021.1975610
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!